Switch theme
Sign up to access all valuation multiples
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
2014
2.2K+
LTM Revenue $684M
LTM EBITDA $99.9M
$633M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Avanos Medical has a last 12-month revenue of $684M and a last 12-month EBITDA of $99.9M.
In the most recent fiscal year, Avanos Medical achieved revenue of $688M and an EBITDA of -$346M.
Avanos Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Avanos Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $673M | $688M | XXX | XXX | XXX |
| Gross Profit | $450M | $380M | XXX | XXX | XXX |
| Gross Margin | 67% | 55% | XXX | XXX | XXX |
| EBITDA | $53.2M | -$346M | XXX | XXX | XXX |
| EBITDA Margin | 8% | -50% | XXX | XXX | XXX |
| Net Profit | $50.5M | -$61.8M | XXX | XXX | XXX |
| Net Margin | 8% | -9% | XXX | XXX | XXX |
| Net Debt | $105M | $80.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Avanos Medical's stock price is $12.
Avanos Medical has current market cap of $571M, and EV of $633M.
See Avanos Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $633M | $571M | XXX | XXX | XXX | XXX | $1.29 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Avanos Medical has market cap of $571M and EV of $633M.
Avanos Medical's trades at 0.9x LTM EV/Revenue multiple, and 6.3x LTM EBITDA.
Analysts estimate Avanos Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Avanos Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $633M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | -1.8x | XXX | XXX | XXX |
| P/E | -1.5x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 7.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAvanos Medical's NTM/LTM revenue growth is -1%
Avanos Medical's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Avanos Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Avanos Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Avanos Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -50% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -750% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -51% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 50% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Avanos Medical acquired XXX companies to date.
Last acquisition by Avanos Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Avanos Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Avanos Medical founded? | Avanos Medical was founded in 2014. |
| Where is Avanos Medical headquartered? | Avanos Medical is headquartered in United States of America. |
| How many employees does Avanos Medical have? | As of today, Avanos Medical has 2.2K+ employees. |
| Who is the CEO of Avanos Medical? | Avanos Medical's CEO is Mr. Michael C. Greiner. |
| Is Avanos Medical publicy listed? | Yes, Avanos Medical is a public company listed on NYS. |
| What is the stock symbol of Avanos Medical? | Avanos Medical trades under AVNS ticker. |
| When did Avanos Medical go public? | Avanos Medical went public in 2014. |
| Who are competitors of Avanos Medical? | Similar companies to Avanos Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Avanos Medical? | Avanos Medical's current market cap is $571M |
| What is the current revenue of Avanos Medical? | Avanos Medical's last 12-month revenue is $684M. |
| What is the current EBITDA of Avanos Medical? | Avanos Medical's last 12-month EBITDA is $99.9M. |
| What is the current EV/Revenue multiple of Avanos Medical? | Current revenue multiple of Avanos Medical is 0.9x. |
| What is the current EV/EBITDA multiple of Avanos Medical? | Current EBITDA multiple of Avanos Medical is 6.3x. |
| What is the current revenue growth of Avanos Medical? | Avanos Medical revenue growth between 2023 and 2024 was 2%. |
| Is Avanos Medical profitable? | Yes, Avanos Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
